Mark Lawler: Financial discrimination against cancer survivors
Mark Lawler, Chair in Translational Cancer Genomics at Queen’s University Belfast, shared a post on X:
“Our paper on financial discrimination against cancer survivors and our data-informed solution makes featured article in this September’s The Lancet Oncology.”
Authors: Mark Lawler, Grazia Scocca, Françoise Meunier
Source: Mark Lawler/X
Dr. Mark Lawler is the Chair in Translational Cancer Genomics and the Associate Director of Postgraduate Studies at Queen’s University Belfast, Centre for Cancer Research and Cell Biology. He is also a Visiting Professor in Human Genetics and Molecular Medicine at the University of Chieti Pescara, Italy. His specialties include genetics, molecular medicine, cancer biology, drug discovery, graduate education, bioethics, science policy, art therapy, and public perception of science.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023